Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

Mendaera announced today that it appointed surgical robotics veteran Eric Davidson as its first chief commercial officer (CCO ...

Mendaera has found a leader with deep medical robotics experience to lead its commercialization push. Eric Davidson has taken ...

Onera Health, a leader in transforming sleep diagnostics and monitoring, is excited to announce the appointment of Maria ...

India's medical device industry, valued at US$12 billion, has become a growing hub for innovation, attracting venture capital ...

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.

The FDA and European Medicines Agency (EMA) have granted several key designations to nipocalimab including: U.S. FDA Fast Track designation in hemolytic disease of the fetus and newborn (HDFN) and ...

Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...

FDA grants priority review tag to JNJ's nipocalimab BLA for gMG and asks for new warnings on GSK & PFE's RSV vaccine labels.

Med Tech & Diagnostics Analysts Matson and Saxon, along with Dr. Kevin Cronin, Assistant Professor of Orthopaedic Surgery at the University ...

In the Jan. 1, 2025, issue of Nature, researchers from the Allen Institute presented a map of areas and cell types where ...